| | Regulation of the Medical Use of Psychedelics and Marijuana |
| | 2,06 | | MB |
| | 446 | | stron |
| | 5820 | | ID | Harvard University |
| | 2001 | | rok |
| | TABLE OF CONTENTS |
| | Preface .1 |
| | Chapter 1 The Evolution of the Regulation of the Medical Uses of Psychedelic Drugs and Marijuana |
| | 5 |
| | Chapter 2 From Pilot Drug to the Present .70 |
| | Chapter 3 The Rise and Fall of FDA’s Pilot Drug Evaluation Staff.130 |
| | Chapter 4 Regulatory, Ethical and Methodological Issues in Psychedelic Research.188 |
| | Chapter 5 Enhanced Protocol Designs for Evaluating Psychedelic Psychotherapy.255 |
| | Chapter 6 Regulation of the Prescription Use of Psychedelic Drugs.299 |
| | References—General370 |
| | References—Federal Register Filings.430 |
| | References—Federal Laws, State Codes and Local Ordinances.434 |
| | References—Legal Cases.437 |